🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The present study will explore the immunogenicity of AVAXIM™ 80U-Pediatric ...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00313950
RATIONALE: Drugs used in chemotherapy, work in different ways to stop the g...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2005-07
Trial ID
NCT00133991
To evaluate the immunogenicity, lot-to-lot consistency and safety of three ...
Status
Completed
Location
Jiangsu Provincial Center for Disease Control and Prevention
Start Date
2021-12-23
Trial ID
NCT05161845
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growt...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2006-05
Trial ID
NCT00369681
Treatments Being Tested
This is a single-arm, Phase II study designed to enroll and treat up to 64 ...
Status
Completed
Location
Florida Cancer Specialists-South
Start Date
2012-10
Trial ID
NCT01626352
Treatments Being Tested
In this single-center, single-arm, prospective, Phase 1/2 study, the safety...
Status
Recruiting
Location
China
Start Date
2025-06-20
Trial ID
NCT07008885
Treatments Being Tested
The purpose of this study is to evaluate the safety and immunogenicity of c...
Status
Completed
Location
Hanbin District Center for Disease Control and Prevention
Start Date
2019-07-26
Trial ID
NCT04111432
The study was designed to test the following hypotheses: In patients with ...
Status
Unknown
Location
Hopital Universitaire
Start Date
2013-01
Trial ID
NCT01820598
Treatments Being Tested
This study is evaluating the safety and immunogenicity of Hib-MenCY-TT vacc...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04-11
Trial ID
NCT00134719
Treatments Being Tested
The aims of this trial are to demonstrate the consistency of three manufact...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-01-06
Trial ID
NCT00148941
Treatments Being Tested